Congress time zone: EEST (Eastern European Summer Time, Helsinki, CET +1)
Tuesday 01 June 16:00-17:30
Aortic valve stenosis and Lp(a): from genetics to physiopathology
Aortic valve calcification: The role of lipoprotein (a)
Florian Kronenberg, Innsbruck, Austria
Genetic factors underlying aortic valve calcification
Johanna Kuusisto, Joensuu, Finland
Monday 31 May 15:00-16:30
Influence of genes on the susceptibility to atherosclerosis
Novel insight into the genetics of hypetriglyceridemia
Jacqueline Dron, Hamilton, Canada
Polygenic and clinical risk scores and their impact on age of onset and prediction of cardiovascular diseases
Samuli Ripatti, Helsinki, Finland
Tuesday 01 June 14:30-16:00
Cell metabolism and vascular health
Role of SIRT3 in mitochondrial dysfuction and cardiovascular diseases
Martin Bennett, United Kingdom
Tuesday 01 June 12:30-14:00
Diet and CVD
Benefits of long-chain omega-3 fatty acids : from bench to bedside
Phil Calder, Southampton, United Kingdom
The evolving story of omega-3 trials and reduction of CVD risk
Jane Armitage, Oxford, United Kingdom
Monday 31 May 16:00-17:30
Novel approaches and future targets to lower circulating triglycerides
ANGPTLs as a novel targets to reduce CVD risk
Sander Kersten, Wageningen, The Netherlands
Role apo apoC-III in the metabolism of triglyceride rich lipoproteins
Marja-Riitta Taskinen, Helsinki, Finland
Monday 31 May 16:00-17:30
Macrophage function and impaired resolution of inflammation in atherosclerosis
Impaired resolution of inflammation – role of lipid mediators
Magnus Bäck, Stockholm, Sweden
Macrophage immunometabolism in atherosclerosis
Ira Tabas, New York, USA
Wednesday 02 June 10:30-12:00
Extracellular matrix components: guardians of vascular health
Dietary polyphenols and arterial stiffness
Guido R.Y. De Meyer, Antwerp, Belgium
The role of smooth muscle cells in plaque stability
Helle F. Joergensen, Cambridge, United Kingdom
Wednesday 02 June 17:00-18:30
Imaging and the vulnerable plaque
CTA Imaging in the Full Assessment of Coronary Disease Noninvasive Approach to Plaque Anatomy, Ischemia and Risk
Patrick Serruys, The Netherlands
Imaging neoatherosclerosis in coronary stent thrombosis
Michael Joner, Munich, Germany
Tuesday 01 June 10:30-12:00
Immunopathological responses elicited by lipoprotein retention in the arterial wall
Are mastcells welcomed in the atherosclerotic lesions?
Petri Kovanen, Helsinki, Finland
Humoral immune responses in the artery wall.
Christoph Binder, Vienna, Austria
Mechanisms of acute coronary syndromes
Filippo Crea, Rome, Italy
Monday 31 May 16:00-17:30
Current insights into the role of gut microbiota in atherosclerosis
Is gut microbiota a risk factor for cardiovascular disease?
Christoph Reinhardt, Mainz, Germany
The impact of diet on gut microbiota in health and disease
Wendy Garrett, Massachusetts, USA
Tuesday 01 June 11:00-12:30
Liver as the center of lipid metabolism
NAFLD: a multisystem disease
Christopher D. Byrne, Southampton, United Kingdom
Triglyceride metabolism in the liver
David E. Cohen, New York, USA
Tuesday 01 June 15:30-17:00
Lymphatics, lipoproteins and the endothelium
Lymphatic system in cardiovascular medicine
Kari Alitalo, Helsinki, Finland
Lymphatics in the Regulation of Intestinal Lipid Mobilization
Gary Lewis, Toronto, Canada
Wednesday 02 June 15:30-17:00
Atherosclerosis in ageing societies
How to optimize CVD risk reduction
Francesco Cosentino, Stockholm, Sweden
Primary prevention in ageing societies
Martin Mortensen, Aarhus, Denmark
Monday 31 May 11:00-12:30
Lipid metabolism and atherothrombosis
How to optimize atherothromobotic therapies to reduce CVD risk
Riitta Lassila, Helsinki, Finland
Platelet activation and inhibition in dyslipidemias
Carlo Patrono, Rome, Italy
Wednesday 02 June 14:00-16:30
Lifestyle and prevention: Secrets to success
Lifestyle and prevention: how do we define success?
Benoit Arsenault, Québec, Canada
Weight reduction and atherosclerotic benefits: from actual evidence to future perspectives
Luc van Gaal, Antwerp, Belgium
